Summary
Response to adalimumab in psoriasis patients previously treated with anti-tumor necrosis factor agents: Subanalysis of BELIEVE
Summary
Adalimumab plus topical treatment (calcipotriol/betamethasone) in the treatment of moderate to severe psoriasis: Response across subgroups in BELIEVE
Summary
Adalimumab plus topical treatment (calcipotriol/betamethasone) in the treatment of moderate to severe psoriasis - Effects on skin, scalp, and nails: Results from BELIEVE
Summary
Efficacy and safety of Xamiol gel compared to calcipotriol scalp solution in patients with scalp psoriasis (NCT01195831)
Summary
LEO 80185 in the treatment of psoriasis vulgaris on the non-scalp regions of the body (Trunk and/or limbs) (NCT01188928)
Summary
Efficacy and safety of calcipotriene plus betamethasone dipropionate gel compared to tacalcitol ointment and gel vehicle alone in patients with psoriasis vulgaris: A randomized controlled trial
Summary
Effects of adalimumab monotherapy versus adalimumab plus betamethasone/calcipotriol combination therapy on patient-reported outcomes in psoriasis patients
Summary
The purpose of this study is to demonstrate the safety and effectiveness of calcipotriene foam in subjects with scalp and body psoriasis (NCT01139580)
Summary
A study comparing LEO 80190 ointment with hydrocortisone ointment, both applied once daily in the treatment of psoriasis vulgaris on the face and intertriginous areas (NCT01007591)
Summary
Efficacy and safety of calcipotriol plus hydrocortisone ointment in psoriasis vulgaris on the face and skin folds (NCT00691002)
This site complies with the HONcode standard for trustworthy health information: